Beck John W 4
4 · Ardea Biosciences, Inc./DE · Filed May 18, 2011
Insider Transaction Report
Form 4
Beck John W
SVP, Finance & Operations, CFO
Transactions
- Award
Common Stock
2011-05-16$5.85/sh+1,500$8,775→ 5,909 total - Exercise/Conversion
Common Stock
2011-05-16$26.04/sh−400$10,416→ 4,409 total - Exercise/Conversion
Common Stock
2011-05-17$25.00/sh−1,000$25,000→ 4,409 total - Exercise/Conversion
Common Stock
2011-05-16$25.34/sh−1,100$27,878→ 4,809 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2011-05-17−1,000→ 6,250 totalExercise: $5.85Exp: 2017-06-14→ Common Stock (1,000 underlying) - Award
Common Stock
2011-05-17$5.85/sh+1,000$5,850→ 5,409 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2011-05-16−1,500→ 7,250 totalExercise: $5.85Exp: 2017-06-14→ Common Stock (1,500 underlying)
Footnotes (4)
- [F1]The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of June 2, 2010.
- [F2]The range of sales prices received was $25.00 to $25.93. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
- [F3]The range of sales prices received was $26.00 to $26.095. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
- [F4]Immediately exercisable, subject to a right of repurchase on behalf of the Issuer that lapsed on January 2, 2008.